Nanosuspension: An Approach to Enhance Solubility of Drugs

Overview

Journal J Adv Pharm Technol Res

Date 2011 Dec 16

PMID 22171298

Citations 127

Authors

Vishal R Patel

Y K Agrawal

Affiliations

Soon will be listed here.

Abstract

One of the major problems associated with poorly soluble drugs is very low bioavailability. The problem is even more complex for drugs like itraconazole, simvastatin, and carbamazepine which are poorly soluble in both aqueous and nonaqueous media, belonging to BCS class II as classified by biopharmaceutical classification system. Formulation as nanosuspension is an attractive and promising alternative to solve these problems. Nanosuspension consists of the pure poorly water-soluble drug without any matrix material suspended in dispersion. Preparation of nanosuspension is simple and applicable to all drugs which are water insoluble. A nanosuspension not only solves the problems of poor solubility and bioavailability, but also alters the pharmacokinetics of drug and thus improves drug safety and efficacy. This review article describes the preparation methods, characterization, and applications of the nanosuspension.

Citing Articles

Advanced drug delivery systems for the management of local conditions.

Lopez-Vidal L, Juskaite K, Ramoller I, Real D, McKenna P, Priotti J Ther Deliv. 2025; 16(3):285-303.

PMID: 40020739 PMC: 11875478. DOI: 10.1080/20415990.2024.2437978.

Improving the Safety of -Dimethylacetamide (DMA) as a Potential Treatment for Preterm Birth in a Pregnant Mouse Model Using a Vaginal Nanoformulation.

Mir A, Acosta T, Concheiro-Guisan M, Yellon S, Patel K, Reznik S bioRxiv. 2025; .

PMID: 39896642 PMC: 11785104. DOI: 10.1101/2025.01.16.633348.

Nanosuspension Innovations: Expanding Horizons in Drug Delivery Techniques.

Jacob S, Kather F, Boddu S, Attimarad M, Nair A Pharmaceutics. 2025; 17(1).

PMID: 39861782 PMC: 11768797. DOI: 10.3390/pharmaceutics17010136.

Silver Nanoparticles from : Evaluation of Potential Ovicidal Activity on Eggs.

Ferraz C, Comerio L, Segantine V, de Assis J, Costa Silva L, Bezerra L Pathogens. 2025; 13(12.

PMID: 39770303 PMC: 11728469. DOI: 10.3390/pathogens13121043.

Peony-shaped zinc oxide nanoflower synthesized via hydrothermal route exhibits promising anticancer and anti-amyloid activity.

Girigoswami A, Deepika B, Udayakumar S, Janani G, Jessy Mercy D, Girigoswami K BMC Pharmacol Toxicol. 2024; 25(1):101.

PMID: 39736727 PMC: 11684297. DOI: 10.1186/s40360-024-00830-x.

References

Keck C, Muller R . Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation. Eur J Pharm Biopharm. 2005; 62(1):3-16. DOI: 10.1016/j.ejpb.2005.05.009. View

Jacobs C, Muller R . Production and characterization of a budesonide nanosuspension for pulmonary administration. Pharm Res. 2002; 19(2):189-94. DOI: 10.1023/a:1014276917363. View

Jia L, Wong H, Cerna C, Weitman S . Effect of nanonization on absorption of 301029: ex vivo and in vivo pharmacokinetic correlations determined by liquid chromatography/mass spectrometry. Pharm Res. 2002; 19(8):1091-6. DOI: 10.1023/a:1019829622088. View

Higgins J, Arrivo S, Thurau G, Green R, Bowen W, Lange A . Spectroscopic approach for on-line monitoring of particle size during the processing of pharmaceutical nanoparticles. Anal Chem. 2003; 75(8):1777-85. DOI: 10.1021/ac0207980. View

Patravale V, Date A, Kulkarni R . Nanosuspensions: a promising drug delivery strategy. J Pharm Pharmacol. 2004; 56(7):827-40. DOI: 10.1211/0022357023691. View

Yang J, Young A, Chiang P, Thurston A, Pretzer D . Fluticasone and budesonide nanosuspensions for pulmonary delivery: preparation, characterization, and pharmacokinetic studies. J Pharm Sci. 2008; 97(11):4869-78. DOI: 10.1002/jps.21380. View

Matteucci M, Brettmann B, Rogers T, Elder E, Williams 3rd R, Johnston K . Design of potent amorphous drug nanoparticles for rapid generation of highly supersaturated media. Mol Pharm. 2007; 4(5):782-93. DOI: 10.1021/mp0700211. View

Chen Y, Liu J, Yang X, Zhao X, Xu H . Oleanolic acid nanosuspensions: preparation, in-vitro characterization and enhanced hepatoprotective effect. J Pharm Pharmacol. 2005; 57(2):259-64. DOI: 10.1211/0022357055407. View

Young T, Mawson S, Johnston K, Henriksen I, Pace G, Mishra A . Rapid expansion from supercritical to aqueous solution to produce submicron suspensions of water-insoluble drugs. Biotechnol Prog. 2000; 16(3):402-7. DOI: 10.1021/bp000032q. View

10.

Merisko-Liversidge E, Liversidge G, Cooper E . Nanosizing: a formulation approach for poorly-water-soluble compounds. Eur J Pharm Sci. 2003; 18(2):113-20. DOI: 10.1016/s0928-0987(02)00251-8. View

11.

Kayser O, Lemke A, Hernandez-Trejo N . The impact of nanobiotechnology on the development of new drug delivery systems. Curr Pharm Biotechnol. 2005; 6(1):3-5. DOI: 10.2174/1389201053167158. View

12.

Sharma P, Denny W, Garg S . Effect of wet milling process on the solid state of indomethacin and simvastatin. Int J Pharm. 2009; 380(1-2):40-8. DOI: 10.1016/j.ijpharm.2009.06.029. View

13.

Peters K, Leitzke S, Diederichs J, Borner K, Hahn H, Muller R . Preparation of a clofazimine nanosuspension for intravenous use and evaluation of its therapeutic efficacy in murine Mycobacterium avium infection. J Antimicrob Chemother. 2000; 45(1):77-83. DOI: 10.1093/jac/45.1.77. View

14.

Mansour H, Rhee Y, Wu X . Nanomedicine in pulmonary delivery. Int J Nanomedicine. 2010; 4:299-319. PMC: 2802043. DOI: 10.2147/ijn.s4937. View

15.

Bond L, Allen S, Davies M, Roberts C, Shivji A, Tendler S . Differential scanning calorimetry and scanning thermal microscopy analysis of pharmaceutical materials. Int J Pharm. 2002; 243(1-2):71-82. DOI: 10.1016/s0378-5173(02)00239-9. View

16.

Wongmekiat A, Tozuka Y, Oguchi T, Yamamoto K . Formation of fine drug particles by cogrinding with cyclodextrins. I. The use of beta-cyclodextrin anhydrate and hydrate. Pharm Res. 2003; 19(12):1867-72. DOI: 10.1023/a:1021401826554. View

17.

Rabinow B, Kipp J, Papadopoulos P, Wong J, Glosson J, Gass J . Itraconazole IV nanosuspension enhances efficacy through altered pharmacokinetics in the rat. Int J Pharm. 2007; 339(1-2):251-60. DOI: 10.1016/j.ijpharm.2007.02.030. View

18.

Itoh K, Pongpeerapat A, Tozuka Y, Oguchi T, Yamamoto K . Nanoparticle formation of poorly water-soluble drugs from ternary ground mixtures with PVP and SDS. Chem Pharm Bull (Tokyo). 2003; 51(2):171-4. DOI: 10.1248/cpb.51.171. View

19.

Hernandez-Trejo N, Kayser O, Steckel H, Muller R . Characterization of nebulized buparvaquone nanosuspensions--effect of nebulization technology. J Drug Target. 2005; 13(8-9):499-507. DOI: 10.1080/10611860500353245. View

20.

Trotta M, Gallarate M, Carlotti M, Morel S . Preparation of griseofulvin nanoparticles from water-dilutable microemulsions. Int J Pharm. 2003; 254(2):235-42. DOI: 10.1016/s0378-5173(03)00029-2. View